A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers.
| Autor: | Ayers, Kristin L.1 (AUTHOR), Ma, Meng1 (AUTHOR), Debussche, Gaspard1 (AUTHOR), Corrigan, David1 (AUTHOR), McCafferty, Jonathan1 (AUTHOR), Lee, Kyeryoung1 (AUTHOR), Newman, Scott1 (AUTHOR), Zhou, Xiang1 (AUTHOR), Hirsch, Fred R.2 (AUTHOR), Mack, Philip C.2 (AUTHOR), Liu, Jane J.1,3 (AUTHOR), Schadt, Eric E.1,2 (AUTHOR) eric.schadt@sema4.com, Chen, Rong1,2 (AUTHOR) rong.chen@sema4.com, Li, Shuyu D.1,2 (AUTHOR) shuyudanli@gmail.com |
|---|---|
| Zdroj: | BMC Cancer. 4/21/2021, Vol. 21 Issue 1, p1-11. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|